Insider Sentiment Summary: Drugs

Demo data is delayed six months. Subscribe today and get current information.  Learn More »
Report Time Period: 
Sentiment Summary

Last 13 Weeks

20-Sep-17 - 19-Dec-17
Buy Ratio:35%


# Net Buyers:55
# Net Sellers:104

Previous 13 Weeks

21-Jun-17 - 19-Sep-17
Buy Ratio:34%
# Net Buyers:58
# Net Sellers:111
Buy Ratio History
Number of Companies Filing
Largest Positive Net Change
CompanyNet Buy AmountChange
Juno Therapeutics, Inc.($407.74K)$220.05M  
Nexvet Biopharma Plc--$76.62M  
Vertex Pharmaceuticals Inc / Ma($56.36M)$50.22M  
Akorn Inc$41.50M$44.35M  
Celgene Corp /de/($355.31K)$40.58M  
New Net Buyers
CompanyNet Buy AmountChange
Akorn Inc$41.50M$44.35M  
Acceleron Pharma Inc$23.83M$26.55M  
Immunomedics Inc$13.87M$14.92M  
Valeant Pharmaceuticals International, Inc.$126.62K$14.68M  
Biogen Inc.$9.47M$10.62M  
Largest Negative Net Change
CompanyNet Buy AmountChange
Kite Pharma, Inc.($675.84M)($653.25M)  
Regeneron Pharmaceuticals Inc($101.37M)($133.51M)  
Loxo Oncology, Inc.($43.34M)($39.41M)  
Synergy Pharmaceuticals, Inc.($24.68M)($24.58M)  
Amicus Therapeutics Inc$20.03K($18.35M)  
New Net Sellers
CompanyNet Buy AmountChange
Regeneron Pharmaceuticals Inc($101.37M)($133.51M)  
Akebia Therapeutics, Inc.($302.48K)($15.17M)  
Acorda Therapeutics Inc($6.35K)($14.09M)  
Advaxis, Inc.($8.15M)($8.17M)  
Corium International, Inc.($2.40M)($4.02M)